
- Volume 0 0
COMPOUNDINGHOTLINE
Q Do you have a recipe to make a metronidazole suspension using Cherry Simple Syrup and Ora-Sweet SF? I need to make it using this prescription: Dose: 20 mg/mL of metronidazole. Instructions: 5 mL twice a day. Total: 300 mL.
A Metronidazole suspension in a base of OraPlus 50%, OraSweet qs ad 100% is reported in the literature. Also reported is a suspension of metronidazole in cherry syrup. This syrup does not suspend insoluble drugs such as metronidazole very readily, creating potential compliance and dosing difficulties.
When a suspending agent such as OraPlus or methylcellulose 1% (preserved) is used as 50% of the preparation, a more elegant preparation is dispensed. With bitter drugs such as metronidazole, patient compliance hinges on the taste. One solution (pardon the pun) is to combine the dose, when administered, with an equal volume of a commercial food-grade chocolate syrup. Another suggestion is the use of metronidazole benzoate, a salt of metronidazole with virtually no associated taste issues. A weight conversion to obtain the correct dose is necessary, because the benzoate moiety contributes a large percentage of the molecular weight. A suggested metronidazole benzoate suspension formulation follows:
Metronidazole 250-mg/5-mL Suspension Calculated to Make 60 mL
Metronidazole benzoate*: 4.80 g
Propylene glycol: To wet
1% methylcellulose gel: 30.00 mL
Flavored syrup qs ad: 60.00 mL
- Wet the metronidazole with propylene glycol to make a stiff paste.
- Levigate in the 1% methylcellulose gel with trituration.
- After the powder is evenly dispersed in the gel, add the flavored syrup, and mix well.
- Refrigerate. Shake well before using.
*Be sure to use the benzoate salt of metronidazole.
Metronidazole benzoate 400 mg = metronidazole 250 mg
Metronidazole benzoate 200 mg = metronidazole 125 mg
No claims are made as to the uses, safety, efficacy, or bioavailability of this product. The formula is for informational purposes only.
E-mail your compounding questions to compounding@pharmacytimes.com
Mr. Erickson is director of professional affairs at Gallipot Inc.
Articles in this issue
over 21 years ago
Bloodstream Infection Risk Is Higher for Diabeticsover 21 years ago
Research Links Diabetes with Alzheimer'sover 21 years ago
Individuals with Chronic Pain Keep Quietover 21 years ago
Association Redesigns Web Siteover 21 years ago
Fibromyalgia Hits Individuals Differentlyover 21 years ago
Procedure May Relieve Agony of Spinal Cord Injuriesover 21 years ago
Europeans Are Slow to Seek Treatmentover 21 years ago
Intervention Curbs Asthma in Childrenover 21 years ago
Vaccine at Birth May Diminish Allergiesover 21 years ago
Asthma in Women Is Greater with Acetaminophen UseNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.